News Vtesse's rare disease drug set for UK early access Vtesse drug "promising" treatment for NPC disease, says regulator.
Views & Analysis Meeting pharmacovigilance standards in the US and Europe Examining statistics on recent inspections gives insight into the issues commonly faced.
News UK regulator updates guidance for health apps MHRA's updated guidance aims to clarify medical device classification.
News UK could quit EU drug regulation system - minister Nothing has been ruled in or out, says George Freeman.
News Brexit: could European Medicines Agency stay in London? Pharma wants single regulatory system to remain.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
